Journal Article Summary

The article investigates the issue of azole resistance in Aspergillus species, particularly focusing on isolates from animals and their environments over the past decade. This topic is significant because azole antifungals are commonly used to treat Aspergillus infections in both humans and animals, and rising resistance could complicate treatment options. Understanding the prevalence and patterns of resistance in animal populations is crucial, as it may have implications for both veterinary and public health.

To conduct this research, the authors performed a systematic review of literature published between 2013 and 2024, analyzing 73 out of 2042 articles that met their criteria. They examined clinical cases involving various animals, including horses, dogs, cats, and zoo animals, and assessed in-vitro susceptibility testing results for different azole antifungals. The findings revealed that non-wild type (NWT) A. fumigatus isolates were present in several animal categories, with zoo animals and wildlife showing a higher prevalence of resistance compared to others. Treatments often involved itraconazole, which was effective in many cases, but the overall data indicated a concerning trend of resistance.

The study has limitations, including the variability in study designs and methodologies, which makes it challenging to draw definitive conclusions. Additionally, the authors noted a lack of comprehensive data from Europe and highlighted the need for more systematic research to monitor azole resistance. Patients and caregivers should discuss these findings with healthcare professionals, especially if they are involved in the care of animals or if they have underlying health conditions that could be affected by fungal infections. Understanding the potential for azole resistance is essential for making informed treatment decisions.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Dieste-Pérez Lucía, Holstege Manon M. C., de Jong Judith E., Heuvelink Annet E.. Azole resistance in Aspergillus isolates from animals or their direct environment (2013–2023): a systematic review. Frontiers in Veterinary Science 2025. DOI: 10.3389/fvets.2025.1507997. PMID: 40182641. PMCID: PMC11967370.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]